drugset
drugset / Trial / NCT01461720

Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery Infarct

NCT01461720 ↗

Phase 2 Unknown 50 enrolled National University of Malaysia Cytopeutics Sdn. Bhd. · collab
Non-randomizedParallel-groupSingle-blindTreatment

Summary

This study aims to determine the efficacy of intravenous transplantation of autologous bone marrow-derived mesenchymal stem cells in patients with acute middle cerebral artery infarct.

Timeline

Start
2012-03
Primary completion
2015-12
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous bone marrow-derived mesenchymal stem cells Cell therapy — Intravenous

Indications

middle cerebral artery infarction